Close
4

Bora CDMO Bora CDMO

X

Find Betahistine Dimesilate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Looking for 54856-23-4 / Betahistine Dimesilate API manufacturers, exporters & distributors?

Betahistine Dimesilate manufacturers, exporters & distributors 1

47

PharmaCompass offers a list of Betahistine Dimesilate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Betahistine Dimesilate manufacturer or Betahistine Dimesilate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Betahistine Dimesilate manufacturer or Betahistine Dimesilate supplier.

PharmaCompass also assists you with knowing the Betahistine Dimesilate API Price utilized in the formulation of products. Betahistine Dimesilate API Price is not always fixed or binding as the Betahistine Dimesilate Price is obtained through a variety of data sources. The Betahistine Dimesilate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Betahistine Dimesilate

Synonyms

Betahistine mesylate, 54856-23-4, Meginalisk, Merislon, Extovyl, Melopat

Cas Number

54856-23-4

Unique Ingredient Identifier (UNII)

X1L0E3R43Y

About Betahistine Dimesilate

A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers.

Betahistine Dimesilate Manufacturers

A Betahistine Dimesilate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Betahistine Dimesilate, including repackagers and relabelers. The FDA regulates Betahistine Dimesilate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Betahistine Dimesilate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Betahistine Dimesilate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Betahistine Dimesilate Suppliers

A Betahistine Dimesilate supplier is an individual or a company that provides Betahistine Dimesilate active pharmaceutical ingredient (API) or Betahistine Dimesilate finished formulations upon request. The Betahistine Dimesilate suppliers may include Betahistine Dimesilate API manufacturers, exporters, distributors and traders.

click here to find a list of Betahistine Dimesilate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Betahistine Dimesilate JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Betahistine Dimesilate Drug Master File in Japan (Betahistine Dimesilate JDMF) empowers Betahistine Dimesilate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Betahistine Dimesilate JDMF during the approval evaluation for pharmaceutical products. At the time of Betahistine Dimesilate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Betahistine Dimesilate suppliers with JDMF on PharmaCompass.

Betahistine Dimesilate GMP

Betahistine Dimesilate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Betahistine Dimesilate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Betahistine Dimesilate GMP manufacturer or Betahistine Dimesilate GMP API supplier for your needs.

Betahistine Dimesilate CoA

A Betahistine Dimesilate CoA (Certificate of Analysis) is a formal document that attests to Betahistine Dimesilate's compliance with Betahistine Dimesilate specifications and serves as a tool for batch-level quality control.

Betahistine Dimesilate CoA mostly includes findings from lab analyses of a specific batch. For each Betahistine Dimesilate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Betahistine Dimesilate may be tested according to a variety of international standards, such as European Pharmacopoeia (Betahistine Dimesilate EP), Betahistine Dimesilate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Betahistine Dimesilate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY